(Q48026862)

7 February 2018

title

The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity (English)

1 reference

7 February 2018

author name string

Hurpin C

1

1 reference

7 February 2018

Rotarioa C

2

1 reference

7 February 2018

Bisceglia H

3

1 reference

7 February 2018

Chevalier M

4

1 reference

7 February 2018

Tartaglia J

5

1 reference

7 February 2018

Erdile L

6

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

16

1 reference

7 February 2018

issue

2-3

1 reference

7 February 2018

page(s)

208-215

1 reference

7 February 2018

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

p53, a potential target for tumor-directed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

T cell-mediated cytotoxicity against p53-protein derived peptides in bulk and limiting dilution cultures of healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900190-4

7 January 2021

10.1016/S0264-410X(97)00190-4

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018